Medical oncology

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS59
Academic Journal
Presents an abstract of the research manuscript `Hepatic artery chemo-embolization in the treatment of metastatic colorectal cancer to the liver,' by A. Harmantas et al.


Related Articles

  • Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma. Ke-Cheng Xu; Li-Zhi Niu; Qiang Zhou; Yi-Ze Hu; De-Hong Guo; Zheng-Ping Liu; Bing Lan; Feng Mu; Ying-Fei Li; Jian-Sheng Zuo // World Journal of Gastroenterology;8/7/2009, Vol. 15 Issue 29, p3664 

    AIM: To evaluate the efficacy of sequential use of transarterial chemoembolization (TACE) and percutaneous cryosurgery for unresectable hepatocellular carcinoma (HCC). METHODS: Four hundred and twenty patients were enrolled in this study. The patients, who were considered to have unresectable...

  • Bacterial Infections Associated with Hepatic Arteriography and Transarterial Embolization for Hepatocellular Carcinoma: A Prospective Study. Chen, Chicher; Tsang, Yuk-Ming; Hsueh, Po-Ren; Huang, Guan-Tarn; Yang, Pei-Ming; Sheu, Jin-Chuan; Lai, Ming-Yang; Chen, Pei-Jer; Chen, Ding-Shinn // Clinical Infectious Diseases;7/1/99, Vol. 29 Issue 1, p161 

    Provides information on a study which determined the exact incidence of and identified the possible risk factors for infectious complications after hepatic arteriography (HA) and transarterial embolization (TAE) for hepatocellular carcinoma (HCC). Clinical characteristics of patients with HCC...

  • Embolization for the Treatment of Hypervascularized Tumors. Bonomo, Guido; Vigna, Paolo Della; Monfardini, Lorenzo; Orgera, Gianluigi; Orsi, Franco // European Journal of Clinical & Medical Oncology;2010, Vol. 2 Issue 4, p38 

    Hypervascular liver tumors include both hepatocellular carcinoma (HCC) and metastatic lesions from neuroendocrine tumors (NETs). Conspicuity of hepatic tumors on diagnostic imaging studies depends on adequate contrast with normal liver parenchyma. As well demonstrated previously, the hepatic...

  • Hepatic artery injection of I-labelled metuximab combined with chemoembolization for intermediate hepatocellular carcinoma: a prospective nonrandomized study. Wu, Lu; Yang, Ye-Fa; Ge, Nai-Jian; Shen, Shu-Qun; Liang, Jun; Wang, Yi; Zhou, Wei-Ping; Shen, Feng; Wu, Meng-Chao // European Journal of Nuclear Medicine & Molecular Imaging;Aug2012, Vol. 39 Issue 8, p1306 

    Purpose: Hepatocellular carcinoma (HCC) is the fifth and seventh most common cause of cancer in men and women, respectively. Transcatheter arterial chemoembolization (TACE) is the standardized therapy for the intermediate stage of HCC. However, the 3-year overall survival remains low (<30 %) in...

  • Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection. Chen, Xiaohong; Zhang, Boheng; Yin, Xin; Ren, Zhenggang; Qiu, Shuangjian; Zhou, Jian // Journal of Cancer Research & Clinical Oncology;May2013, Vol. 139 Issue 5, p773 

    Purpose: To explore the effect of lipiodolized transarterial chemoembolization (lip-TACE) in hepatocellular carcinoma (HCC) patients at different risk of recurrence after curative resection. Methods: One thousand nine hundred and twenty-four consecutive HCC patients who underwent curative...

  • Arterial Chemoembolization with Mitomycin C Microcapsules followed by Transcatheter Hepatic Artery Embolization for Hepatocellular Carcinoma. Ohnishi, Kunihiko; Sugita, Shujiro; Nomura, Fumio; Iida, Shinji; Tanabe, Yuichiro // American Journal of Gastroenterology;Sep1987, Vol. 82 Issue 9, p876 

    Of 66 patients with hepatocellular carcinoma, 32 were treated by intraarterial injection of mitomycin C microcapsules (group A)and 34 patients by intraarterial injection of mitomycin C microcapsules followed by transcatheter hepatic artery embolization (group B). Measurable tumor regression...

  • Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: lessons learned. Bloomston, Mark; Al-Saif, Osama; Klemanski, Dori; Pinzone, Joseph J.; Martin, Edward W.; Palmer, Bryan; Guy, Gregory; Khabiri, Hooman; Ellison, E. Christopher; Shah, Manisha H. // Journal of Gastrointestinal Surgery;Mar2007, Vol. 11 Issue 3, p264 

    Background: Hepatic artery chemoembolization (HACE) is a treatment option in the management of metastatic carcinoid. We reviewed our experience to identify potential factors that influence survival.Methods: The records of 122 patients with metastatic carcinoid tumor...

  • Temporary Balloon Occlusion of the Common Hepatic Artery for Yttrium-90 Glass Microspheres Administration in a Patient with Hepatocellular Cancer and Renal Insufficiency. Smith, Justin; Murthy, Ravi; Lahoti, Amit; Odisio, Bruno; Avritscher, Rony; Chasen, Beth; Mahvash, Armeen // Case Reports in Radiology;2013, p1 

    The most severe complication of yttrium-90 therapy is gastrointestinal ulceration caused by extrahepatic dispersion of microspheres. Standard pretreatment planning requires extensive angiographic evaluation of the hepatic circulation and embolization of hepatoenteric collaterals; however, in...

  • Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization. Ikeda, Masafumi; Mitsunaga, Shuichi; Shimizu, Satoshi; Ohno, Izumi; Takahashi, Hideaki; Okuyama, Hiroyuki; Kuwahara, Akiko; Kondo, Shunsuke; Morizane, Chigusa; Ueno, Hideki; Satake, Mitsuo; Arai, Yasuaki; Okusaka, Takuji // Journal of Gastroenterology;May2014, Vol. 49 Issue 5, p932 

    Background: The efficacy of sorafenib for hepatocellular carcinoma (HCC) patients refractory to transcatheter arterial chemoembolization (TACE) has not yet been clarified. We investigated the efficacy of sorafenib in HCC patients who were refractory to TACE (sorafenib group) and retrospectively...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics